Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nevirapine vs Ritonavir-boosted Lopinavir in ART HIV-infected Adults in a Resource-limited Setting; a Randomized, Multicenter, Parallel Group Study

NCT01772940 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Saint Pierre as lead sponsor.

NCT NCT01772940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01772940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nevirapine vs Ritonavir-boosted Lopinavir in ART HIV-infected Adults in a Resource-limited Setting; a Randomized, Multicenter, Parallel Group Study
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2011
Enrollment
425 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection